Loading…
Type: Track A clear filter
Wednesday, September 16
 

12:55pm EDT

Track A Chair
Wednesday September 16, 2026 12:55pm - 1:00pm EDT

Speakers
avatar for Diana Gowe

Diana Gowe

Director, Global Strategic Analytics, Johnson & Johnson

Wednesday September 16, 2026 12:55pm - 1:00pm EDT

1:00pm EDT

First Look: What 135 Life Sciences CI Professionals Told Us Actually Works in 2026
Wednesday September 16, 2026 1:00pm - 1:30pm EDT
Join us for the debut release of this year's Annual Life Sciences CI Survey, capturing insights from 135 competitive intelligence professionals across the industry, covering:

  • Industry Benchmarks: CI budget and team size trends, AI maturity, effective delivery channels, and stakeholder engagement models
  • Maximizing CI Impact: What actually drives senior leadership reach, strategic influence, and stakeholder satisfaction, backed by new correlation analysis
  • AI Adoption: Practical CI use cases, internal pressure to adopt, realized ROI, and the barriers still holding teams back


Speakers
avatar for Matt Blandford

Matt Blandford

VP, Business Development, Sedulo Group

Wednesday September 16, 2026 1:00pm - 1:30pm EDT
Junior Ballroom C

1:35pm EDT

Decision Intelligence: What Integrated Insights Actually Looks Like
Wednesday September 16, 2026 1:35pm - 2:05pm EDT
  • Explore the convergence of CI, analytics, forecasting, market research, and strategy  

  • Debate where intelligence organizations should sit in the future  

  • Examine emerging operating models across pharma
Moderators
avatar for Heather Rumancik

Heather Rumancik

Director of Competitive Intelligence, AbbVie
Heather Rumancik is a competitive intelligence leader with a passion for connecting people, data, and technology to generate meaningful business insights. As Director of Competitive Intelligence at AbbVie, she focuses on generating intelligence to support strategic decision-making... Read More →
Speakers
avatar for Anshuman Panigrahi

Anshuman Panigrahi

Senior Director, Global Strategy and Analytics, Johnson & Johnson
Anshuman Panigrahi is Senior Director, Global Strategy & Analytics at Johnson & Johnson Innovative Medicine, where he leads portfolio analytics, forecasting, competitive intelligence and market research capabilities that inform enterprise planning and investment decisions. With more... Read More →
avatar for Hezekiah Blake

Hezekiah Blake

Senior Director, Competitive Intelligence, Amgen

Wednesday September 16, 2026 1:35pm - 2:05pm EDT
Junior Ballroom C

2:10pm EDT

How to Deliver Intelligence that Motivates Action: The 5 Key Elements of a Compelling CI Narrative
Wednesday September 16, 2026 2:10pm - 2:40pm EDT
Our job as CI thought partners is to engage expert audiences, who are also human beings with limited attention and memory. Stories, relative to pure statistics & facts, are what stick best in their minds. Stories are more likely to impact beliefs and motivate action. Our minds are literally wired to respond to stories. 

But how can we leverage "storytelling" in communicating CI?

Even when the task is to describe trends, statistics & scientific facts, there are aspects we can leverage from great "storytelling" to better influence the way our audience feels about the CI we deliver. 

Attendees will hear about 5 key elements of compelling CI "storytelling". 

Speakers
avatar for Eileen Faucher, Ph.D.

Eileen Faucher, Ph.D.

Founder & Managing Director, Brass Tacks Insights
Eileen Faucher has been leading competitive intelligence for 16 years, including a decade as Founder and Managing Director at Brass Tacks Insights. In this role, she leads a team of PhD- and MD-level experts in developing long-term, competitive readiness thought partnerships. She... Read More →
Wednesday September 16, 2026 2:10pm - 2:40pm EDT
Junior Ballroom C

3:25pm EDT

Faster Alerts Aren't Faster Decisions: Closing the Internal Half of Competitive Intelligence
Wednesday September 16, 2026 3:25pm - 3:55pm EDT
Avizum's agents monitor thousands of sources continuously and across languages, in production today across big pharma and small biotech and more than 30 indications. Alerts are validated and delivered within twenty minutes, filtered against intelligence questions rather than keyword strings, with the reasoning shown on every one. The first half of this session is 
that system running live. Seven years of work sits behind it, including the early wins nobody agreed on and the long flat stretch where the compounding was real but invisible — Avizum, introduced here for the first time, is where that work arrives. The second half addresses a problem better monitoring does not solve. In Day and Schoemaker's study of 380 organizations, whenever a company was late to a signal, someone inside had known all along; the leadership team had not. External monitoring is getting easier, which makes the internal half the bottleneck. Field insight thins at every level on the way up and reaches decision-makers late, or not at all, and the causes are organizational rather than technical. No one owns the internal layer, so no one builds it — and the country teams holding the best insight have the least incentive to share it. The session closes on what closing that gap requires, and what Avizum is building to do it.  


KEY TAKEAWAYS  
· See continuous, multi-language competitive monitoring running in production across 30+ indications  
· Understand why twenty-minute validated alerts change which questions CI can be asked to answer  
· Recognize the internal insight gap as an ownership problem rather than a technology problem  
· Assess where your own organization loses field signal on its way to the leadership team 

Speakers
avatar for Rita Lopes

Rita Lopes

VP, New Product Development, ATACANA Group
VP of New Product Development Rita Lopes holds a Ph.D. in Molecular Oncology and has a research background in Developmental Neuroscience. Over the past 15+ years, she has held Business and Market Intelligence roles across the pharmaceutical industry, with a focus on Oncology and Rare... Read More →
Wednesday September 16, 2026 3:25pm - 3:55pm EDT
Junior Ballroom C

4:00pm EDT

AI-Assisted Oncology CI Toolkit: SOC Benchmarking, Abstract Prioritization, and Outcome Prediction
Wednesday September 16, 2026 4:00pm - 4:30pm EDT
Applying AI to structured oncology data enables complementary CI workflows spanning current landscape assessment, evidence prioritization, and outcome prediction. 
 
  • SOC benchmarking: Visualize competitive and market dynamics through AI-powered maps integrating current and emerging SOC, key regimens, efficacy, safety, network meta-analysis results, market-share estimates, and future scenario modeling. 
  • Abstract prioritization: Multi-LLM ranking of abstracts using impact scores and supporting rationales aligned with customer-defined priorities. 
  • Outcome prediction: Forecast upcoming or immature trial outcomes using machine learning and LLM models trained on structured oncology data. 

Speakers
avatar for Bruno Larvol

Bruno Larvol

CEO, LARVOL
Bruno Larvol is the CEO of LARVOL, an AI-first oncology intelligence company serving leading pharmaceutical and healthcare organizations worldwide. With a background in strategy consulting and deep expertise in the pharma and biotech industries, Bruno leads a globally distributed... Read More →
Wednesday September 16, 2026 4:00pm - 4:30pm EDT
Junior Ballroom C

4:30pm EDT

Panel: How will AI Impact the Speed and Success Rate of Drug Development?
Wednesday September 16, 2026 4:30pm - 5:15pm EDT
Pointers to put Competitive Intelligence Teams ahead of the curve
 
  • AI promises to accelerate drug discovery, with better compounds entering the clinic that both reduce the time and money required to develop a drug. Is this already happening? The panel will discuss the challenges of applying AI and machine learning to compound discovery, preclinical testing, identifying the right patients, biomarker development, trial management, and ultimately in silico trials.
  • Discuss what CI Teams should look for to tell hype from reality as companies claim AI based success. Discuss which emerging trends, companies, technologies, and development milestones to pay attention to.  
  • Examine how AI-driven advances could reshape competitive strategy over the next decade.

Moderators
avatar for Ben Weintraub

Ben Weintraub

President, inThought Research

Speakers
avatar for Eddine Maiza

Eddine Maiza

Global Head, Competitive Intelligence, Gilead
avatar for Christopher Roselle, Ph.D.

Christopher Roselle, Ph.D.

Director, Strategy & Operations, Recursion
Christopher Roselle is the Director of Strategy & Operations at Recursion, where he works
across the company’s platform and pipeline on portfolio and operational strategy.
Prior to joining Recursion, Chris worked at Boston Consulting Group, advising
biopharmaceutical companies on... Read More →
Wednesday September 16, 2026 4:30pm - 5:15pm EDT
Junior Ballroom C
 
Thursday, September 17
 

8:25am EDT

Track A Chair
Thursday September 17, 2026 8:25am - 8:40am EDT

Speakers
avatar for Mukesh Kumar, Ph.D.

Mukesh Kumar, Ph.D.

President, KV Group
Dr. Mukesh Kumar is the President of the KV Group. Mukesh has more than 20 years of experience in conducting high quality evidence based primary research, developing and synthesizing information, competitive and pipeline analysis. His experience in pharmaceutical industry, especially... Read More →
Thursday September 17, 2026 8:25am - 8:40am EDT

8:30am EDT

Panel: Competitive Intelligence Across the Asset Lifecycle: Turning Early Signals Into Better Portfolio Decisions
Thursday September 17, 2026 8:30am - 9:15am EDT
  • Identify competitive signals early enough to influence development—not just launch  

  • Adapt intelligence priorities across discovery, development, launch and lifecycle management  

  • Build scenarios that evolve with the asset  

  • Balance commercial and scientific intelligence throughout development  

  • Determine which intelligence questions matter most at each stage

Moderators
avatar for Brian Adams, Ph.D.

Brian Adams, Ph.D.

Director of Global Competitive Intelligence and Integrated Insights, Rare Diseases, UCB

Speakers
avatar for Azusa Tanaka, Ph.D.

Azusa Tanaka, Ph.D.

Director, Customer Insights, Regeneron

avatar for Heather Rumancik

Heather Rumancik

Director of Competitive Intelligence, AbbVie
Heather Rumancik is a competitive intelligence leader with a passion for connecting people, data, and technology to generate meaningful business insights. As Director of Competitive Intelligence at AbbVie, she focuses on generating intelligence to support strategic decision-making... Read More →
avatar for Alice Readick

Alice Readick

Senior Director, Commercial Strategy & Planning, Exelixis
Alice Readick is Senior Director, Commercial Strategy & Planning at Exelixis, leading New Product Planning activities across the early- and late-stage oncology portfolio. 
Thursday September 17, 2026 8:30am - 9:15am EDT
Junior Ballroom C

9:20am EDT

From Insights to Strategy Alignment & Decision Confidence Across Markets: A “Workshop-In-a-Box” Approach
Thursday September 17, 2026 9:20am - 9:50am EDT
  • This talk will explore how market research and competitive intelligence can be brought together to create alignment and turn insights into confident strategic decisions.
  • It will examine a real-world “Workshop-in-a-Box” case study, demonstrating how a global launch strategy can be scaled across markets while accounting for local differences in treatment pathways, competition, and access.
  • The session will cover practical lessons on designing workshops that translate global strategy into locally relevant priorities, actionable plans, and clear ownership across teams.

Speakers
avatar for Will Torres

Will Torres

Consultant, Lifescience Dynamics
Thursday September 17, 2026 9:20am - 9:50am EDT
Junior Ballroom C

9:55am EDT

Beyond AI: The Human Advantage in Pharma Competitive Intelligence
Thursday September 17, 2026 9:55am - 10:25am EDT
FENIX conducted qualitative interviews with 42 pharma stakeholders and CI professionals to explore how AI is being adopted, where it creates value and where it continues to fall short. Drawing on these perspectives and selected case studies, this session examines the emerging CI ecosystem and how human and artificial intelligence can work together. 

Key takeaways:
  • Where AI is already transforming CI workflows, and where it falls short
  • Why human expertise remains essential for interpreting subtle signals and strategic meaning
  • How AI’s speed and scale combine with human context, judgment, and leadership






Speakers
avatar for Pedro Fontana, MBA

Pedro Fontana, MBA

Vice President, Growth & Strategy, Fenix Group International
Pedro Fontana is VP of Growth and Strategy at FENIX, a global life sciences strategy and competitive intelligence consultancy. His 10+ years of experience advising leading pharma companies include roles as a Principal in IQVIA’s Asset and Portfolio Strategy practice and as a Senior... Read More →
avatar for Erika Dahl, Ph.D.

Erika Dahl, Ph.D.

  Senior Project Lead, Fenix Group International 
Erika Dahl is a competitive intelligence leader at Fenix Group International, a life sciences consulting and technology company primarily partnering with pharmaceutical, biotechnology, and healthcare organizations. She supports life science organizations with market insights and strategic... Read More →
Thursday September 17, 2026 9:55am - 10:25am EDT
Junior Ballroom C

11:15am EDT

Your Competitor's Website Changed 20 Minutes Ago. Who's Going to Notice?
Thursday September 17, 2026 11:15am - 11:45am EDT
Automating the watching layer of pharma CI: peer playbooks, AI triage, and a live build you can copy. 
 
Pharma CI teams still do the watching by hand: weekly sweeps of long link lists, the same 60 to 80 pages checked two or three times a day, 200-message mornings where half the alerts do not matter. The signals that matter move first on public pages: registry amendments, agency calendars, competitor HCP copy, congress portals, HTA decisions. 
 
This working session covers what peer teams watch and what they built on top of it: change events routed into Microsoft 365 flows, therapy-area mailboxes, weekly AI-filtered digests, and congress triage that replaced manual contractor sweeps. We'll build automations live on stage in under ten minutes, and every attendee leaves with a competitor monitoring starter pack. 
 
Attendees will take away 
 
- Which public sources pharma CI programs actually monitor, drawn from a real dataset of active monitors, and where the monitored volume concentrates 
- Four architecture patterns for organizing a monitoring program: by marketed asset, by therapy area, by geography, or by client program 
- The automation patterns peers already run: change events into Microsoft 365 flows, functional mailbox routing, and weekly important-only AI digests 
 
Who should attend 
CI practitioners and leads at pharma and biotech, CI agencies and consultancies, CROs offering regulatory or competitive intelligence services, plus regulatory intelligence, medical affairs, and market access professionals who own a watchlist. 
 
Session level 
Beginner to Intermediate. Practitioner-focused, no specific vendor tooling required to apply the material. 
 
Materials attendees receive 
Speakers
avatar for Eric Do Couto

Eric Do Couto

Head of Marketing, Visualping
Eric Do Couto is Head of Marketing & GTM at Visualping, the website change-detection platform with users in 85% of the Fortune 500 and more than 2 million users. His vantage point is the aggregate: what thousands of monitoring programsobserveh, how they route alerts, and which habits... Read More →
Thursday September 17, 2026 11:15am - 11:45am EDT
Junior Ballroom C
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.